Medinice S.A. (ICE.WA)
- Previous Close
7.85 - Open
7.98 - Bid 7.77 x --
- Ask 7.85 x --
- Day's Range
7.76 - 7.99 - 52 Week Range
7.00 - 13.50 - Volume
8,024 - Avg. Volume
13,546 - Market Cap (intraday)
60.149M - Beta (5Y Monthly) 1.34
- PE Ratio (TTM)
-- - EPS (TTM)
-0.67 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Medinice S.A. focuses on creating, developing, and commercializing medical technologies for cardiology and cardio surgery. The company provides advisory services in the field of commercialization of research and development products; and undertakes preclinical tests, clinical trials, and obtaining a certificate for sale of medical technology. Medinice S.A. was incorporated in 2012 and is headquartered in Warsaw, Poland.
www.medinice.plRecent News: ICE.WA
View MorePerformance Overview: ICE.WA
Trailing total returns as of 4/29/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ICE.WA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ICE.WA
View MoreValuation Measures
Market Cap
60.15M
Enterprise Value
55.60M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
233.89
Price/Book (mrq)
1.98
Enterprise Value/Revenue
256.46
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
19,987.77%
Return on Assets (ttm)
37.51%
Return on Equity (ttm)
65.82%
Revenue (ttm)
188k
Net Income Avi to Common (ttm)
37.58M
Diluted EPS (ttm)
-0.67
Balance Sheet and Cash Flow
Total Cash (mrq)
9.12M
Total Debt/Equity (mrq)
0.43%
Levered Free Cash Flow (ttm)
18.44M